Study of the involvement of K+ channels in the peripheral antinociception of the κ-opioid receptor agonist bremazocine

European Journal of Pharmacology

Volumn 494, Issue 2-3, 2004, Pages 155-160

  Amarante, Luiz H ^a   Alves, Daniela P ^a   Duarte, Igor D G ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

opioid receptor; Bremazocine; Carrageenan; Peripheral antinociception; Potassium channel

Indexed keywords

4 AMINOPYRIDINE; ANTINOCICEPTIVE AGENT; BREMAZOCINE; CARRAGEENAN; CHARYBDOTOXIN; DEQUALINIUM; GLIBENCLAMIDE; KAPPA OPIATE RECEPTOR AGONIST; NORBINALTORPHIMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN E2; TETRYLAMMONIUM; TOLBUTAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANALGESICS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BENZOMORPHANS; CHARYBDOTOXIN; CYCLIC GMP; DEQUALINIUM; GLYBURIDE; HYPERALGESIA; MALE; NALTREXONE; NITRIC OXIDE; PERIPHERAL NERVOUS SYSTEM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; SIGNAL TRANSDUCTION; TETRAETHYLAMMONIUM; TOLBUTAMIDE;

EID: 2942752068     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.05.009     Document Type: Article

References (38)

1. + channels in the peripheral antinociceptive effect inducible by dipyrone. Eur. J. Pharmacol. 444:2002;47-52
2. Amarante L.H., Duarte I.D.G. The κ-opioid agonist (±)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. Eur. J. Pharmacol. 454:2002;19-23
3. Cook N.S., Quast U. Potassium channel pharmacology. Cook N.S. Potassium channels: structure, classification, function and therapeutic potential. 1990;181-255 Ellis Horwood, Chichester
4. Duarte I.D.G., Ferreira S.H. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 221:1992;171-174
5. Duarte I.D.G., Lorenzetti B.B., Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur. J. Pharmacol. 186:1990;289-293
6. Dunn P.M. Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurons in culture. Eur. J. Pharmacol. 252:1994;189-194
7. Fürst S. Transmitters involved in antinociception in the spinal cord. Brain Res. Bull. 48:1999;129-141
8. Garcia M.L., Hamnner M., Knaus A.G., Kaczorowski G.J. Pharmacology of potassium channels. Adv. Pharmacol. 39:1997;425-471
9. Horan P.J., Porreca F. Lack of cross-tolerance between U69, 593 and bremazocine suggests kappa-opioid receptor multiplicity in mice. Eur. J. Pharmacol. 239:1993;93-98
10. Horan P.J., De Costa B.R., Rice K.C., Porreca F. Differential antagonism of U69, 593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice. J. Pharmacol. Exp. Ther. 257:1991;1154-1161
11. Horan P.J., de Costa B.R., Rice K., Haaseth R.C., Hruby V.J., Porreca F. Differential antagonism of bremazocine-and U69, 593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse. J. Pharmacol. Exp. Ther. 266:1993;926-933
12. Ikeda K., Kobayashi T., Kumanishi T., Niki H., Yano R. Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia. Neurosci. Res. 38:2000;113-116
13. Ko M., Butelman E.R., Woods J.H. Activation of peripheral κ-opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. J. Pharmacol. Exp. Ther. 289:1999;378-385
14. Kolesnikov Y., Jain S., Wilson R., Pasternak G.W. Peripheral κ-1-opioid receptor-mediated analgesia in mice. Eur. J. Pharmacol. 310:1996;141-143
15. Kuriyama H., Kitamura K., Hiroyuki N. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacol. Rev. 47:1995;387-431
16. MacAndrew J., Patel R.P., Jo H., Cornwell T., Lincoln T., Moellering D., White C.R., Matalon S., Darley-Usmar V. The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease. Semin. Perinatol. 21:1997;351-366
17. Millan M.J. κ-opioid receptors and analgesia. Trends Pharmacol. Sci. 11:1990;70-76
18. + channels from mammalian skeletal muscle. Nature. 313:1985;316-318
19. + channel blockers on antinociception induced by alpha 2-adrenoceptor, GABA B and kappa-opioid receptor agonists. Br. J. Pharmacol. 110:1993;1049-1054
20. Ocaña M., Del Pozo E., Barrios M., Robles L.I., Baeyens J.M. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur. J. Pharmacol. 186:1990;377-378
21. + channel blockers antagonise morphine-but not U50, 488H-induced antinociception. Eur. J. Pharmacol. 230:1993;203-207
22. + channels by diclofenac. Eur. J. Pharmacol. 438:2002;85-91
23. + channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom. Eur. J. Pharmacol. 469:2003;57-64
24. Porreca F., Mosberg H.I., Husrt R., Hruby V.J., Burks T.F. Roles of um, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J. Pharmacol. Exp. Ther. 230:1984;341-348
25. Randall L.D., Selitto J.J. A method for measurement of analgesic activity on inflamed tissues. Arch. Int. Pharmacodyn. 111:1957;209-219
26. + channels. Br. J. Pharmacol. 129:2000;110-114
27. Römer D., Büscher H., Hill R.C., Maurer R., Petcher T.J., Welle H.B.A., Bakel H.C.C.K., Akkerman A.M. Bremazocine: a potent, long-acting opiate kappa-agonist. Life Sci. 27:1980;971-978
28. Rudy B. Diversity and ubiquity of K channels. Neuroscience. 25:1988;729-749
29. + channels in the rat PGE2-induced hyperalgesic paw. Br. J. Pharmacol. 134:2001;127-131
30. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol. 400:2000;67-71
31. Song Z.H., Takemori A.E. Involvement of spinal kappa opioid receptors in the antinociception induced by intrathecally administered corticotropin- releasing factor in mice. J. Pharmacol. Exp. Ther. 254:1990;363-368
32. Sousa A.M., Prado W.A. The dual effect of a nitric oxide donor in nociception. Brain Res. 897:2001;9-19
33. Ulens C., Daenens P., Tytgat J. The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands. Eur. J. Pharmacol. 385:1999;239-245
34. Vinegar R., Schreiber W., Hugo R. Biphasic development of carrageenan edema in rats. J. Pharmacol. Exp. Ther. 166:1969;96-103
35. Wan Fan L., Tanaka S., Park Y., Sasaki K., Ma T., Tai Tien L., Rockhold R.W., Ho I.K. Butorphanol dependence and withdrawal decrease hippocampal K2-opioid receptor binding. Brain Res. 958:2002;277-290
36. Werz M.A., Macdonald R.L. Opioid peptides with differential affinity for μ and δ receptors decrease sensory neuron calcium-dependent action potentials. J. Pharmacol. Exp. Ther. 227:1983;394-401
37. Werz M.A., Macdonald R.L. Opioid peptides selective for mu- and delta-opiate receptors reduce calcium-dependent action potential duration by increasing potassium conductance. Neurosci. Lett. 42:1983;173
38. Werz M.A., Macdonald R.L. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J. Pharmacol. Exp. Ther. 234:1985;49-56